Biofrontera Inc. (BFRI) vs Cellectar Biosciences, Inc. (CLRB)

A side-by-side comparison of Biofrontera Inc. and Cellectar Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Biofrontera Inc. logo
BFRI
Biofrontera Inc.
$11M
$0.87HealthcareDelayed quote: Oct 6, 2026, 10:03 AM EDT
Cellectar Biosciences, Inc. logo
CLRB
Cellectar Biosciences, Inc.
$13M
$1.66HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT

Total return — BFRI vs CLRB

growth of $100 · dividends reinvested · last 5y
BFRI -99.0% (-60.1%/yr)CLRB -99.1% (-60.9%/yr)BFRI compounded faster over this window
0100200300Start $10020222023202420252026$1$1
BFRI CLRB

BFRI vs CLRB: by the numbers

  • •CLRB is the larger company ($13M vs $11M market cap).
  • •Both run net losses; CLRB's is the smaller (0.00% vs -13.78% net margin).

Metrics side by side

Valuation

MetricBFRICLRB
P/S ratio0.24N/A
P/B ratio1.870.44

Profitability

MetricBFRICLRB
Gross margin84.45%0.00%
Operating margin-21.94%0.00%
Net margin-13.78%0.00%
ROE-106.87%-74.73%
ROIC-32.27%-74.94%

Growth (annualized)

MetricBFRICLRB
Revenue CAGR (5Y)15.55%N/A
Total return CAGR (5Y)N/A-60.51%

Go deeper

Full BFRI analysisFull CLRB analysisInteractive comparison tool

Dig into the metrics

Biofrontera ROECellectar Biosciences ROEBiofrontera operating marginCellectar Biosciences operating marginBiofrontera revenue growthCellectar Biosciences revenue growthBiofrontera free cash flowCellectar Biosciences free cash flow

Biofrontera & Cellectar Biosciences appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.